US Patent 10517886 Drug formulations
Patent 10517886 was granted and assigned to Astex Pharmaceuticals on December, 2019 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
January 25, 2018
Date of Patent
December 31, 2019
Patent Applicant
Patent Application Number
15879802
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 10517886 Drug formulations
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.